These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 32887023)

  • 1. Bone metabolism regulation: Implications for the treatment of bone diseases.
    Yao D; Huang L; Ke J; Zhang M; Xiao Q; Zhu X
    Biomed Pharmacother; 2020 Sep; 129():110494. PubMed ID: 32887023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the bone microenvironment in multiple myeloma.
    Roodman GD
    J Bone Miner Metab; 2010 May; 28(3):244-50. PubMed ID: 20127498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone metabolism, mineral homeostasis and its pharmacological modulation.
    Seibel MJ
    Clin Lab; 2004; 50(5-6):255-64. PubMed ID: 15209433
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of osteoclast differentiation and collagen antibody-induced arthritis by CTHRC1.
    Jin YR; Stohn JP; Wang Q; Nagano K; Baron R; Bouxsein ML; Rosen CJ; Adarichev VA; Lindner V
    Bone; 2017 Apr; 97():153-167. PubMed ID: 28115279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response of human rheumatoid arthritis osteoblasts and osteoclasts to adiponectin.
    Krumbholz G; Junker S; Meier FMP; Rickert M; Steinmeyer J; Rehart S; Lange U; Frommer KW; Schett G; Müller-Ladner U; Neumann E
    Clin Exp Rheumatol; 2017; 35(3):406-414. PubMed ID: 28079506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A specific subtype of osteoclasts secretes factors inducing nodule formation by osteoblasts.
    Henriksen K; Andreassen KV; Thudium CS; Gudmann KN; Moscatelli I; Crüger-Hansen CE; Schulz AS; Dziegiel MH; Richter J; Karsdal MA; Neutzsky-Wulff AV
    Bone; 2012 Sep; 51(3):353-61. PubMed ID: 22722081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bone and its diseases. II. The dialog between osteoblasts and osteoclasts].
    Ziegler R
    Dtsch Med Wochenschr; 1995 Apr; 120(16):571-2. PubMed ID: 7736948
    [No Abstract]   [Full Text] [Related]  

  • 8. Research on Bone Cells in Health and Disease.
    Győri DS
    Int J Mol Sci; 2024 Aug; 25(16):. PubMed ID: 39201445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of Bone Targeting Drugs.
    Stapleton M; Sawamoto K; Alméciga-Díaz CJ; Mackenzie WG; Mason RW; Orii T; Tomatsu S
    Int J Mol Sci; 2017 Jun; 18(7):. PubMed ID: 28644392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocrine disruptors and bone metabolism.
    Agas D; Sabbieti MG; Marchetti L
    Arch Toxicol; 2013 Apr; 87(4):735-51. PubMed ID: 23192238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cross-talk between osteoclasts and osteoblasts in response to strontium treatment: involvement of osteoprotegerin.
    Peng S; Liu XS; Huang S; Li Z; Pan H; Zhen W; Luk KD; Guo XE; Lu WW
    Bone; 2011 Dec; 49(6):1290-8. PubMed ID: 21925296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flavonoids: Classification, Function, and Molecular Mechanisms Involved in Bone Remodelling.
    Ramesh P; Jagadeesan R; Sekaran S; Dhanasekaran A; Vimalraj S
    Front Endocrinol (Lausanne); 2021; 12():779638. PubMed ID: 34887836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteoprotegerin deficiency attenuates strontium-mediated inhibition of osteoclastogenesis and bone resorption.
    Peng S; Liu XS; Zhou G; Li Z; Luk KD; Guo XE; Lu WW
    J Bone Miner Res; 2011 Jun; 26(6):1272-82. PubMed ID: 21611968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-host cell interactions in the bone disease of myeloma.
    Fowler JA; Edwards CM; Croucher PI
    Bone; 2011 Jan; 48(1):121-8. PubMed ID: 20615487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The beneficial effect of icaritin on osteoporotic bone is dependent on the treatment initiation timing in adult ovariectomized rats.
    Peng S; Zhang G; Zhang BT; Guo B; He Y; Bakker AJ; Pan X; Zhen W; Hung L; Qin L; Leung WN
    Bone; 2013 Jul; 55(1):230-40. PubMed ID: 23486180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of the TGF-β Superfamily on Osteoclasts/Osteoblasts Balance in Physiological and Pathological Bone Conditions.
    Jann J; Gascon S; Roux S; Faucheux N
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33066607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of cobalt and chromium ions at clinically equivalent concentrations after metal-on-metal hip replacement on human osteoblasts and osteoclasts: implications for skeletal health.
    Andrews RE; Shah KM; Wilkinson JM; Gartland A
    Bone; 2011 Oct; 49(4):717-23. PubMed ID: 21689801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [TSH affects bone metabolism. Surprising skeletal changes in genetically modified mice].
    Lindstedt G
    Lakartidningen; 2004 Feb; 101(6):476-7. PubMed ID: 15004943
    [No Abstract]   [Full Text] [Related]  

  • 19. Systemically available bone morphogenetic protein two and seven affect bone metabolism.
    Dumic-Cule I; Brkljacic J; Rogic D; Bordukalo Niksic T; Tikvica Luetic A; Draca N; Kufner V; Trkulja V; Grgurevic L; Vukicevic S
    Int Orthop; 2014 Sep; 38(9):1979-85. PubMed ID: 25030962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone as a Target Organ in Rheumatic Disease: Impact on Osteoclasts and Osteoblasts.
    Baum R; Gravallese EM
    Clin Rev Allergy Immunol; 2016 Aug; 51(1):1-15. PubMed ID: 26411424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.